Page URL:

Prostate cancer gene mutation raises risk of death by threefold

13 May 2019
Appeared in BioNews 998

A mutation that raises a prostate cancer patient's risk of death threefold has been discovered. 

Patients with a harmful variant of the gene RB1 were almost seven times as likely to relapse after treatment with standard chemotherapy, as well as having a threefold higher risk of death overall. 

'We identified one particular genetic mutation that seems to indicate that tumours are going to be very aggressive, and that the affected men need the most intensive treatment we have available,' said Johann de Bono, Regius professor of cancer research at the Institute of Cancer Research (ICR), and an author of the study.

The team investigated 444 tumour samples from 429 men with advanced prostate cancer by sequencing the DNA and measuring the activity of genes and the features of the tumour tissue. The gene that stood out most in terms of survival and reaction to treatment was the RB1 gene. 

Other genetic mutations with potential therapeutic applications were also discovered, including mutations in the gene p53 and an androgen receptor gene, which were associated with an increased likelihood of relapse after standard chemotherapy. Mutations in the DNA repair genes BRCA1 and BRCA2, among others, were found to be relatively common among advanced prostate cancer patients, but had no apparent effect on treatment or survival rates. 

The researchers hope that the findings could lead to a screening programme in patients to determine whether they might benefit from more intensive treatment. It could also be the starting point for the development of a targeted therapy for advanced prostate cancer with an RB1 mutation. 

Professor Paul Workman, chief executive of the ICR, said: 'The crucial thing now is that we make use of this information, by developing a test to identify affected men and to make sure they receive the best treatments we have available today, while also focusing our efforts on improving options for the future.'

The study was published in the journal PNAS

30 September 2019 - by Dr Jennifer Frosch 
Men who have had fertility treatment to assist conception in the past have a higher risk of developing prostate cancer, a Swedish cohort study has reported...
23 September 2019 - by Dr Jennifer Frosch 
A gene mutation previously associated with breast and ovarian cancer has been found to double the risk of prostate cancer among men...
24 June 2019 - by Georgia Everett 
A large international study has identified the cancer risk associated with hundreds of mutations in BRCA genes. The findings will help improve accuracy when interpreting genetic test information on BRCA genes...
25 March 2019 - by Martha Henriques 
Matt Hancock, secretary of state for health, has been widely criticised by scientists and doctors for misconstruing the results of a genetic test that he took...
3 September 2018 - by Isobel Steer 
Finnish researchers have identified two possible mutations in one gene that are both correlated with prostate cancer...
18 June 2018 - by Dr Charlott Repschlager 
Sixty-three novel gene variants linked to prostate cancer in men have been discovered...
16 January 2017 - by Annabel Slater 
Canadian scientists have identified a genetic fingerprint that indicates which prostate cancer tumours may develop into a more aggressive form of the disease after treatment...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.